Further to its news release of July 17, 2025, Thiogenesis Therapeutics Corp. (TSXV: TTI) ("Thiogenesis" or the "Company") is very pleased to announce that, due to overwhelming investor demand, it has ...

Patients with history of metabolic syndrome have increased risk for cardio-kidney-metabolic diseases and multimorbidity.

Genetics and metabolomics markers in all combinations significantly mediated the association between frailty status and type 2 diabetes.

Check out our PLTR stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.